The total return over the past 12 months is +75.70% vs. +17.61% for the S&P 500. So far it's up +7.47% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +75.70% | +28.77% | +23.07% | +15.97% | +15.96% | +15.41% |
| Total Return CAGR | +75.70% | +28.77% | +23.07% | +15.97% | +15.96% | +15.41% |
| Revenue CAGR | +5.87% | +16.95% | +16.05% | +7.72% | +11.25% | +17.50% |
| Net Income CAGR | +6.34% | +20.91% | +26.00% | +3.60% | +18.31% | +16.60% |
| EPS CAGR | +13.97% | +23.53% | +20.93% | +7.83% | +20.27% | +16.46% |
| Free Cash Flow CAGR | (9.90%) | +12.09% | +12.12% | +11.43% | +11.02% | +16.46% |
| Operating Cash Flow CAGR | +10.73% | +20.71% | +19.90% | +14.62% | +13.61% | +18.21% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
United Therapeutics Corporation (UTHR)
| Year | Start Value | End Value | UTHR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 7995.90 | 8592.90 | +7.47% | +9.22% | (1.75%) |
| 2025 | 5790.19 | 7995.90 | +38.09% | +17.72% | +20.37% |
| 2024 | 3608.45 | 5790.19 | +60.46% | +24.89% | +35.57% |
| 2023 | 4563.53 | 3608.45 | (20.93%) | +26.19% | (47.12%) |
| 2022 | 3545.93 | 4563.53 | +28.70% | (18.17%) | +46.87% |
| 2021 | 2490.91 | 3545.93 | +42.35% | +28.74% | +13.61% |
| 2020 | 1445.42 | 2490.91 | +72.33% | +18.37% | +53.96% |
| 2019 | 1787.08 | 1445.42 | (19.12%) | +31.22% | (50.34%) |
| 2018 | 2427.90 | 1787.08 | (26.39%) | (4.56%) | (21.83%) |
| 2017 | 2353.72 | 2427.90 | +3.15% | +21.70% | (18.55%) |
